Google Scholar: citas
Blood-based multivariate methylation risk score for cognitive impairment and dementia
Koetsier, J. (Maastricht University)
Cavill, R. (Maastricht University)
Reijnders, R. (Maastricht University)
Harvey, J. (University of Exeter)
Homann, J. (University of Münster)
Kouhsar, M. (University of Exeter)
Deckers, K. (Maastricht University)
Köhler, S. (Maastricht University)
Eijssen, L.M.T. (Maastricht University)
van den Hove, D.L.A. (University of Wuerzburg. Dr. Manuel Nagel)
Demuth, I. (Charité-Universitätsmedizin Berlin)
Düzel, S. (Max Planck Institute for Human Development)
Smith, R.G. (University of Exeter)
Smith, A.R. (University of Exeter)
Burrage, J. (University of Exeter)
Walker, E.M. (University of Exeter)
Shireby, G. (University of Exeter)
Hannon, E. (University of Exeter)
Dempster, E. (University of Exeter)
Frayling, T. (University of Exeter)
Mill, J. (University of Exeter)
Dobricic, V. (University of Lübeck)
Johannsen, Peter (Danish Dementia Research Centre)
Wittig, M. (Christian-Albrechts-University of Kiel)
Franke, A. (Christian-Albrechts-University of Kiel)
Vandenberghe, R. (KU Leuven)
Schaeverbeke, J. (KU Leuven)
Freund-Levi, Y. (Södertälje Hospital)
Frölich, L. (Medical Faculty Mannheim/Heidelberg University)
Scheltens, P. (Vrije Universiteit Amsterdam)
Teunissen, C.E. (Vrije Universiteit Amsterdam)
Frisoni, G. (Geneva University)
Blin, O. (Aix-Marseille University-CNRS)
Richardson, J.C. (GlaxoSmithKline R&D (Regne Unit))
Bordet, R. (Université de Lille)
Engelborghs, S. (Vrije Universiteit Brussel (VUB))
de Roeck, E. (University of Antwerp)
Martinez-Lage, P. (Fundación CITA Alzheimer (Sant Sebastià, País Basc))
Tainta, M. (Fundación CITA Alzheimer (Sant Sebastià, País Basc))
Lleó, Alberto (Institut de Recerca Sant Pau)
Sala, I. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Popp, J. (University of Zürich)
Peyratout, G. (University Hospital of Lausanne (CHUV))
Verhey, F. (Maastricht University)
Tsolaki, M. (Balkan Center)
Andreasson, Ulf (The Sahlgrenska Academy at University of Gothenburg)
Blennow, K. (University of Science and Technology of China and First Affiliated Hospital of USTC)
Zetterberg, H. (University of Wisconsin-Madison)
Streffer, J. (AC Immune SA)
Vos, S.J.B. (Maastricht University)
Lovestone, S. (University of Oxford)
Visser, P.J. (Södertälje Hospital)
Lill, C.M. (South Kensington Campus)
Bertram, L. (University of Lübeck)
Lunnon, K. (University of Exeter)
Pishva, E. (University of Exeter)
Universitat Autònoma de Barcelona

Fecha: 2024
Resumen: The established link between DNA methylation and pathophysiology of dementia, along with its potential role as a molecular mediator of lifestyle and environmental influences, positions blood-derived DNA methylation as a promising tool for early dementia risk detection. In conjunction with an extensive array of machine learning techniques, we employed whole blood genome-wide DNA methylation data as a surrogate for 14 modifiable and non-modifiable factors in the assessment of dementia risk in independent dementia cohorts. We established a multivariate methylation risk score (MMRS) for identifying mild cognitive impairment cross-sectionally, independent of age and sex (P = 2. 0 × 10). This score significantly predicted the prospective development of cognitive impairments in independent studies of Alzheimer's disease (hazard ratio for Rey's Auditory Verbal Learning Test (RAVLT)-Learning = 2. 47) and Parkinson's disease (hazard ratio for MCI/dementia= 2. 59). Our work shows the potential of employing blood-derived DNA methylation data in the assessment of dementia risk. Highlights: We used whole blood DNA methylation as a surrogate for 14 dementia risk factors. Created a multivariate methylation risk score for predicting cognitive impairment. Emphasized the role of machine learning and omics data in predicting dementia. The score predicts cognitive impairment development at the population level.
Derechos: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. Creative Commons
Lengua: Anglès
Documento: Article ; recerca ; Versió publicada
Materia: Alzheimer's disease ; DNA methylation ; Parkinson's disease ; Aging ; Dementia ; Epigenetics ; Machine learning ; Mild cognitive impairments ; Risk prediction
Publicado en: Alzheimer's & dementia, Vol. 20 Núm. 10 (october 2024) , p. 6682-6698, ISSN 1552-5279

DOI: 10.1002/alz.14061
PMID: 39193899


17 p, 2.2 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados

 Registro creado el 2025-03-10, última modificación el 2025-07-18



   Favorit i Compartir